Day: February 14, 2025

SCOTTSDALE, Ariz., Feb. 13, 2025 (GLOBE NEWSWIRE) — Yerbaé Brands Corp. (TSX-V: YERB.U; OTCQX: YERBF) (“Yerbaé” or the “Company”), a plant-based functional beverage company, today announced a new partnership with Savannah Distributing Company Inc. (“Savannah Distributing”) to distribute its 12oz functional beverage product line across 172 Kroger locations throughout the State of Georgia. As part of this strategic agreement, Savannah Distributing, a family-owned and locally operated premium beverage distributor with over 85 years of service to Georgia retailers, will handle the distribution of Yerbaé’s popular functional drinks to Kroger, the largest grocery chain in the United States. “Partnering with Savannah Distributing marks a significant milestone in our journey to expand Yerbaé’s availability throughout Georgia,” said Todd...

TORONTO, Feb. 13, 2025 (GLOBE NEWSWIRE) — BE Resources Inc. (the “Company” or “BE Resources“) (TSXV: BER.H) is pleased to provide the following corporate update and announce that, further to its press release dated January 6, 2025, the TSX Venture Exchange (the “Exchange“) has accepted the Company’s trading resumption application and the common shares of the Company (the “Shares”) are expected to commence trading on the NEX shortly. Trading in the Shares will resume on February 18, 2025. As previously announced, the Company’s non-binding letter of intent (the “LOI”) with Bio Graphene Solutions Inc. (“BGS”), announced on August 17, 2020, and extended multiple times, most recently until December 31, 2024, has been terminated without renewal. During the period the LOI was effective, the Company...

NextNRG, Inc. will Trade Under the New Ticker Nasdaq: NXXT MIAMI, Feb. 13, 2025 (GLOBE NEWSWIRE) — EzFill Holdings, Inc. (“EzFill” and the “Company”) (Nasdaq: EZFL), a leading mobile fueling company, today announced the pricing of a public offering of 5,000,000 shares of common stock at a price to the public of $3.00 per share, for gross proceeds of $15,000,000, before deducting underwriting discounts and offering expenses. In addition, EzFill has granted the underwriters a 45-day option to purchase up to an additional 750,000 shares of common stock to cover over-allotments, if any. EzFill today also announced the closing of its previously announced share exchange agreement with NextNRG Holding Corp. Effective February 14, 2025, the Company will change its name from “EzFill Holdings, Inc.” to “NextNRG, Inc.” The Company’s common...

MONTREAL, Feb. 13, 2025 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a specialty biopharmaceutical company focused on the commercialization of innovative therapies that have the potential to redefine standards of care, today announced that it has resumed distribution of EGRIFTA SV® (tesamorelin for injection), following correspondence from the U.S. Food and Drug Administration (FDA) that allows the Company to release two recently manufactured batches of EGRIFTA SV®. The product is ready for immediate shipment to network pharmacies. “We remain committed to providing EGRIFTA SV® to people with HIV and we truly appreciate the FDA’s collaboration to get the treatment back to the patients who rely on it,” said Christian Marsolais, PhD, Senior Vice President and Chief Medical...

Montevideo, Uruguay, Feb. 13, 2025 (GLOBE NEWSWIRE) — MercadoLibre, Inc. (Nasdaq: MELI) (http://www.mercadolibre.com) announces that it intends to release financial results for its fourth fiscal quarter ending December 31, 2024, on February 20, 2025.  The Company will host its earnings results video conference, as well as a conference call and audio webcast, on February 20, at 5:00 p.m. Eastern Time. In order to access our video webcast and the live audio, investors, analysts and the market in general may access the following link at https://event.choruscall.com/mediaframe/webcast.html?webcastid=wKKfxfA5 to attend the live event. To participate in our conference call Q&A, investors, analysts and the market in general may access the following link https://hdr.choruscall.com/?$Y2FsbHR5cGU9MiZyPXRydWUmaW5mbz1jb21wYW55LXBob25l...

ZUG, Switzerland, Feb. 14, 2025 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs, today announced the pricing of an underwritten offering of 5,000,000 of its ordinary shares, CHF 0.01 nominal value per share, at a price of $20.00 per share, for total gross proceeds of $100 million, before deducting underwriting discounts and commissions and offering expenses (the “Offering”). The oversubscribed Offering is expected to close on or about February 18, 2025, subject to satisfaction of customary closing conditions. Before closing, the new shares will be issued out of the Company’s existing capital band (Kapitalband), bringing the total number of registered...

ZUG, Switzerland, Feb. 13, 2025 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs, today announced the pricing of an underwritten offering of 5,000,000 of its ordinary shares, CHF 0.01 nominal value per share, at a price of $20.00 per share, for total gross proceeds of $100 million, before deducting underwriting discounts and commissions and offering expenses (the “Offering”). The oversubscribed Offering is expected to close on or about February 18, 2025, subject to satisfaction of customary closing conditions. Before closing, the new shares will be issued out of the Company’s existing capital band (Kapitalband), bringing the total number of registered...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Feb. 13, 2025 (GLOBE NEWSWIRE) — Euro Sun Mining Inc., (TSX: ESM) (“Euro Sun” or the “Company”) is pleased to announce that it has closed a final tranche (the “Final Tranche”) of its previously announced non-brokered private placement financing of units of the Company (the “Offering”). Pursuant to the closing of the Final Tranche, the Company issued 5,480,000 units of the Company (each a “Unit” and collectively, the “Units”) at a price of C$0.05 per Unit for gross proceeds of C$274,000. Each Unit consists of one common share of the Company (each, a “Common Share”) and one common share purchase warrant (each a “Warrant”). Each Warrant will entitle the holder to acquire one additional Common Share of the Company at an exercise price...